Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study

Human protein C concentrate in pediatric septic patients

(2017) Giovanni Landoni et al.   Signa Vitae

Administration of protein C concentrates in patients without congenital deficit: a systematic review of the literature

(2017) Simona Silvetti et al.   Signa Vitae

Decreasing mortality with drotrecogin alfa in high risk septic patients A meta-analysis of randomized trials in adult patients with multiple organ failure and mortality >40%

(2017) Massimiliano Greco et al.   Signa Vitae

Cost awareness of physicians in intensive care units: a multicentric national study

(2015) Romain Hernu et al.   INTENSIVE CARE MEDICINE

Should cost considerations be included in medical decisions? Yes

(2015) B. Guidet et al.   INTENSIVE CARE MEDICINE

Acquiring knowledge in intensive care: merits and pitfalls of randomized controlled trials

(2015) Luciano Gattinoni et al.   INTENSIVE CARE MEDICINE

Low-dose heparin during extracorporeal membrane oxygenation treatment in adults

(2015) Hye Ju Yeo et al.   INTENSIVE CARE MEDICINE

Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012

(2014) Kirsi-Maija Kaukonen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Use and reimbursement of off-label drugs in pediatric anesthesia: the Italian experience

(2014) Ida Salvo et al.   PEDIATRIC ANESTHESIA

Non-activated plasma-derived PC improves amputation rate of children undergoing sepsis

(2014) Andrea Piccin et al.   THROMBOSIS RESEARCH

Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*

(2013) David F. Gaieski et al.   CRITICAL CARE MEDICINE

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

(2013) R. P. Dellinger et al.   INTENSIVE CARE MEDICINE

Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock

(2013) Andrea Morelli et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Non-activated protein C rescue treatment in Wilms tumour associated hepatic sinusoidal obstructive syndrome

(2013) Francesco De Leonardis et al.   PEDIATRIC BLOOD & CANCER

Protein C zymogen in adults with severe sepsis or septic shock

(2013) M. Crivellari et al.   Medicina Intensiva

An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition*

(2012) Huifang Zhao et al.   CRITICAL CARE MEDICINE

The rise and fall of drotrecogin alfa (activated)

(2012) Jean-Louis Vincent   LANCET INFECTIOUS DISEASES

Drotrecogin Alfa (Activated) in Adults with Septic Shock

(2012) V. Marco Ranieri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia

(2011) Alessandra Carobbio et al.   AMERICAN JOURNAL OF HEMATOLOGY

PROTEIN C CONCENTRATE AS ADJUVANT TREATMENT IN NEONATES WITH SEPSIS-INDUCED COAGULOPATHY

(2010) Lidia Decembrino et al.   SHOCK

Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery

(2009) Martina Crivellari et al.   INTENSIVE CARE MEDICINE

Protein C concentrate to restore physiological values in adult septic patients

(2008) Fabio Baratto et al.   INTENSIVE CARE MEDICINE